Gene Therapy

Dow AgroSciences Highlights Partnership With Sangamo in Wall Street Presentation

Published in Gene Therapy Weekly, June 21st, 2007

Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced that its partner, Dow AgroSciences, LLC highlighted the successful collaboration between the two companies in a recent presentation to investors on Wall Street. The presentation made by Daniel R. Kittle, Ph.D., Dow AgroSciences vice president of Research and Development, was part of the Merrill Lynch Agricultural Chemicals Conference in New York.

"We continue to be very impressed with our partnership with Sangamo and with the overall progress of our collaboration," said Kittle. "The scientific milestones that we have achieved mark key events in the application of the ZFP technology toward trait generation and trait...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2007-06-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry